Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 18 Issue: 2, February 2018



Meet Our Editorial Board Member free to download

Volume:18   Issue: 2
Pp: 107-107
J.L.-S. Au
DOI: 10.2174/156800961802180115100706
Published on: 14 January, 2018



Editorial: Oncolytic Virus and Gene Thearapy Application: Update 2018 free to download

Volume:18   Issue: 2
Pp: 108-108
Masato Abei
DOI: 10.2174/156800961802180115100950
Published on: 14 January, 2018



Oncolytic Viruses: The Best is Yet to Come

Volume:18   Issue: 2
Pp: 109-123
Chantal G. Lemay, Brian A. Keller, Robert E. Edge, Masato Abei and John C. Bell*
DOI: 10.2174/1568009617666170206111609
Published on: 05 February, 2017




Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System

Volume:18   Issue: 2
Pp: 124-138
Vincenzo Cerullo*, Cristian Capasso, Markus Vaha-Koskela, Otto Hemminki and Akseli Hemminki*
DOI: 10.2174/1568009617666170502152352
Published on: 02 May, 2017




Emergence of Ad-Mediated Combination Therapy Against Cancer: What to Expect?

Volume:18   Issue: 2
Pp: 139-152
JinWoo Hong and Chae-Ok Yun*
DOI: 10.2174/1568009617666170222123406
Published on: 22 February, 2017




The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer

Volume:18   Issue: 2
Pp: 153-161
Mizuho Sato-Dahlman and Masato Yamamoto*
DOI: 10.2174/1568009617666170222123925
Published on: 22 February, 2017




Oncolytic Herpes Simplex Virus Vectors Fully Retargeted to Tumor- Associated Antigens

Volume:18   Issue: 2
Pp: 162-170
Hiroaki Uchida*, Hirofumi Hamada, Kenji Nakano, Heechung Kwon, Hideaki Tahara, Justus B. Cohen and Joseph C. Glorioso
DOI: 10.2174/1568009617666170206105855
Published on: 05 February, 2017




Oncorine, the World First Oncolytic Virus Medicine and its Update in China

Volume:18   Issue: 2
Pp: 171-176
Min Liang*
DOI: 10.2174/1568009618666171129221503
Published on: 29 November, 2017




Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

Volume:18   Issue: 2
Pp: 177-187
Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis*
DOI: 10.2174/1568009617666170222125035
Published on: 22 February, 2017




Oncolytic Virotherapy and Gene Therapy Strategies for Hepatobiliary Cancers

Volume:18   Issue: 2
Pp: 188-201
Takeshi Yamada, Yukako Hamano, Naoyuki Hasegawa, Emiko Seo, Kuniaki Fukuda, Kazunari K. Yokoyama*, Ichinosuke Hyodo and Masato Abei*
DOI: 10.2174/1568009617666170330123841
Published on: 30 March, 2017




Oncolytic Virus: Regulatory Aspects from Quality Control to Clinical Studies

Volume:18   Issue: 2
Pp: 202-208
Teruhide Yamaguchi* and Eriko Uchida
DOI: 10.2174/1568009617666170222142650
Published on: 22 February, 2017




TGF-β1 Causes EMT by Regulating N-Acetyl Glucosaminyl Transferases via Downregulation of Non Muscle Myosin II-A through JNK/P38/PI3K Pathway in Lung Cancer

Volume:18   Issue: 2
Pp: 209-219
Ghulam Jilany Khan, Yingsheng Gao, Ming Gu, Lai Wang, Sara Khan, Farah Naeem, Herve Semukunzi, Debmalya Roy, Shengtao Yuan* and Li Sun*
DOI: 10.2174/1568009617666170807120304
Published on: 07 August, 2017